Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.
Condition(s):Non-melanoma Skin CancerLast Updated:April 8, 2022Recruiting
Include Studies Not Open or Pending
Condition(s):Non-melanoma Skin CancerLast Updated:April 8, 2022Recruiting
Condition(s):Skin Cancer, Non-MelanomaLast Updated:November 30, 2023Recruiting
Condition(s):Squamous Cell Carcinoma of the SkinLast Updated:February 2, 2023Recruiting
Condition(s):MelanomaLast Updated:December 15, 2023Recruiting
Condition(s):Carcinoma, Basal Cell; Carcinoma, Cutaneous Squamous CellLast Updated:October 10, 2023Recruiting
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:February 12, 2024Recruiting
Condition(s):Squamous Cell Cancer; Squamous Cell Carcinoma; Skin Cancer; Non-melanoma Skin CancerLast Updated:August 30, 2023Recruiting
Condition(s):Squamous Cell Carcinoma of the SkinLast Updated:August 8, 2023Recruiting
Condition(s):Actinic Keratoses; Aging; Non-Melanoma Skin CancerLast Updated:March 4, 2024Recruiting
Condition(s):Non-melanoma Skin CancerLast Updated:September 22, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.